Wednesday 12 November 2014, Amsterdam
The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019.
The report segments this market on the basis of product, cell type, application, and end user. Among various applications, the regenerative medicines is expected to account for the largest share in 2014 and is expected to account for the fastest-growing segment in the cell expansion market, owing to technological advancement due to which new products are being launched in the market. Furthermore, rising investments by companies and government for research is another major reason for the growth of this market.
Based on geography, the global cell expansion market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2014. The large share of this region can be attributed to various factors including increasing government support for cancer and stem cell research and increasing prevalence of chronic diseases in this region.
Prominent players in the cell expansion market are Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck Millipore (U.S.), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Sigma-Aldrich Corporation (U.S.), Terumo BCT (U.S.), and Thermo Fisher Scientific Inc. (U.S.).
Publish date : October 2014
Report code : ASDR-157413
Pages : 186
ASDReports.com contact: S. Koomen
ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216